Cervical cancer trials in Israel

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  Where

  Hadera, Haifa, Jerusalem, Petah Tikva, Tel Aviv

  Age

  18 years and over

  People

  1,023 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07216703 · EU 2025-521514-26-00
• Phase 1/2Taking people
  A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  Where

  Haifa, Petah Tikva, Ramat Gan, Tel Aviv

  Age

  18 years and over

  People

  1,109 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT04895709
• No phaseTaking people
  Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer

  Where

  Haifa

  Age

  18 years to 85 years

  People

  200

  Run by

  Rambam Health Care Campus

  See details and how to joinNCT06196190